Clinical Trial Update: Reduction of Ischemia-Reperfusion Mediated Cardiac Injury in Subjects Undergoing Coronary Artery Bypass Graft Surgery [Phase 2]

View source ↗

Summary

Phase 2 clinical trial evaluating reduction of ischemia-reperfusion–mediated cardiac injury in subjects undergoing coronary artery bypass graft surgery has been…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Coronary Artery Disease

Snippet

Sponsor: Mallinckrodt | Conditions: Coronary Artery Bypass Surgery | Phase 2 | Status: TERMINATED